SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001174947-15-000657
Filing Date
2015-04-20
Accepted
2015-04-20 17:27:18
Documents
11
Period of Report
2015-04-20

Document Format Files

Seq Description Document Type Size
1 PRE 14A b407642_pre14a.htm PRE 14A 1280774
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC logo_sareptaside-pms.jpg GRAPHIC 36148
4 GRAPHIC spacer.gif GRAPHIC 43
5 GRAPHIC v407642_chrt-bar1.jpg GRAPHIC 53562
6 GRAPHIC v407642_chrt-bar2.jpg GRAPHIC 54252
7 GRAPHIC v407642_chrt-bar3.jpg GRAPHIC 84058
8 GRAPHIC v407642_chrt-bar4.jpg GRAPHIC 86067
9 GRAPHIC v407642_chrt-pie.jpg GRAPHIC 45244
10 GRAPHIC v407642_pc1.jpg GRAPHIC 521741
11 GRAPHIC v407642_pc2.jpg GRAPHIC 372611
  Complete submission text file 0001174947-15-000657.txt   3011010
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-14895 | Film No.: 15781369
SIC: 2834 Pharmaceutical Preparations